Focal adhesion kinase (FAK) prevents apoptosis in many cell types. We have reported that tyrosine residues in FAK are dephosphorylated and FAK is degraded during mannitol-induced apoptosis in human neuroblastoma cells. Several studies suggest that FAK dephosphorylation and degradation are separate events. The current study defines the relationship between FAK dephosphorylation and degradation in neuroblastoma cells using okadaic acid (OA). OA, a serine phosphatase inhibitor, promotes serine/threonine phosphorylation, which in turn blocks tyrosine phosphorylation. OA induced focal adhesion loss, actin cytoskeleton disorganization, and cellular detachment, which corresponded to a loss of FAK Tyr 397 phosphorylation. These changes preceded caspase-3 activation, Akt and MAP kinase activity loss, protein ubiquitination, and cellular apoptosis. Insulin-like growth factor-I prevented mannitol-induced, but not OA-induced, substrate detachment and FAK Tyr 397 dephosphorylation, and the effects of OA on FAK Tyr 397 phosphorylation were irreversible. The proteolytic degradation of FAK is temporally distinct from its tyrosine dephosphorylation, occurring when apoptotic pathways are already initiated and during a generalized destruction of signaling proteins. Therefore, agents resulting in the dephosphorylation of FAK may be beneficial for therapeutic treatment, irrespective of FAK protein levels, as this may result in apoptosis, which cannot be prevented by growth factor signaling. Neoplasia (2003) 5, 405 -416
Introduction
Neuroblastoma, a pediatric tumor arising from improper differentiation of the neural crest, is largely chemoresistant in children over 12 months of age [1] . Long-term survival rates are inadequate, and over 40% of children die of metastatic disease [2] , with primary metastatic sites including the bone, liver, and lungs [3 -5] . Many chemotherapeutic agents induce a caspase-8 -dependent apoptotic death in tumor cells [6] . However, neuroblastoma tumors often have defects in caspase-8 -mediated apoptotic pathways, or overexpress antiapoptotic proteins of the Bcl-2 family, which may explain their chemoresistant behavior [7] . Therefore, in our laboratory, we have focused on alternative ways to induce apoptosis in human neuroblastoma cells, primarily to understand which biochemical pathways to target during neuroblastoma treatment.
We have shown that mannitol, which causes hyperosmotic stress in cells, induces apoptosis in both neuroblastic (N-type) and substrate-adherent (S-type) cells derived from heterogeneous neuroblastoma tumors [8 -10] . Mannitol induces caspase-3 activation within 3 to 9 hours, DNA fragmentation within 12 hours, and membrane alterations by 24 hours after treatment [8 -10] . We have also shown that mannitol treatment leads to morphological changes by 4 hours, with disruptions in actin cytoskeleton and degradation of both the survival protein Akt and focal adhesion kinase (FAK) [11] . This coincides with a loss of focal adhesion sites, cell detachment, and eventual cell death [11] . FAK activation appears to be essential in preventing anoikis [12] , a form of apoptosis that occurs when anchoragedependent cells detach from their substrate [13] . Therefore, these changes have led us to postulate that mannitol induces an anoikis-like death through its effects on FAK.
FAK is a cytoplasmic tyrosine kinase central in many critical cellular pathways [12, 14, 15] . FAK is tyrosine-phosphorylated upon integrin ligand binding [16] or downstream of ligand binding by growth factor receptors [17, 18] . FAK is located at focal adhesion sites where it forms complexes with downstream signaling molecules, such as phosphatidylinositol-3-kinase, Grb2, Shc, Src, and paxillin [16] . FAK activation at focal adhesion sites leads to cytoskeletal reorganization, cellular adhesion, and survival.
Microinjection of an anti-FAK antibody or FAK antisense oligonucleotides, preventing FAK activation, induces apoptosis [15, 19] . Conversely, overexpression of FAK prevents apoptosis caused by cellular detachment [14] , ultraviolet irradiation [20] , hydrogen peroxide, or etoposide [21] .
Results from previous studies suggest that FAK dephosphorylation and degradation are both coupled to anoikis [22] . However, other studies suggest that FAK dephosphorylation and degradation are not directly connected [23] . Therefore, to help clarify the role of FAK in neuroblastoma cell death, we examined its modification during anoikis induced by okadaic acid (OA), an inhibitor of the serine/threonine protein phosphatases 1 (PP1) and 2A (PP2A). OA induces apoptosis in a wide variety of cell types, including mouse keratinocytes [24] , renal epithelial tumor cells [25] , oral squamous carcinoma cells [26, 27] , lung fibroblasts [28] , and cultured neuronal cells [29, 30] . OA-induced apoptosis occurs through several mechanisms, including phosphorylation of p53 [31] and upregulation of the Fas receptor [26] . OA also results in caspase-2, caspase-3, caspase-7, and caspase-9 in multiple cell types, with no activation of caspase-8 [32] . However, the major observation in OA-treated cells is the disruption of the actin cytoskeleton [33, 34] . Therefore, in this study, we examined the effect of OA on FAK phosphorylation, FAK degradation, and apoptosis to determine the role of FAK in neuroblastoma cell apoptosis.
In the current study, we show that OA induces a loss of focal adhesions, disorganization of the actin cytoskeleton, cellular detachment, and cellular rounding. These events correspond with a loss of FAK phosphorylation on Tyr 397 , serine phosphorylation and degradation of paxillin, activation of caspase-3, loss of Akt and MAP kinase, protein ubiquitination, and detection of apoptosis by flow cytometry. Insulinlike growth factor-I (IGF-I) prevents mannitol-induced, but not OA-induced, substrate detachment and FAK Tyr 397 dephosphorylation, and the effects of OA on FAK Tyr 397 phosphorylation were irreversible. These results suggest that OA causes an irreversible change in paxillin or another upstream signaling molecule that disrupts focal adhesion complexes and prevents FAK activation and autophosphorylation. Finally, the proteolytic degradation of FAK is temporally distinct from its tyrosine dephosphorylation, occurring when apoptotic pathways are already initiated and during a generalized destruction of signaling proteins. These results suggest that FAK dephosphorylation and degradation are separable processes. Therefore, agents resulting in the dephosphorylation of FAK may be beneficial for therapeutic treatment, irrespective of FAK protein levels, as this may result in apoptosis, which cannot be prevented by growth factor signaling.
Materials and Methods

Materials
Antibodies against phosphorylated FAK (pFAK, pY397, and pS722) were purchased from Biosource International (Camarillo, CA). Anti-FAK monoclonal and PY20 antiphosphotyrosine antibodies were purchased from Transduction Laboratories (Lexington, KY). Antibodies against phosphorylated and unphosphorylated Akt and mitogen-activated protein kinase (MAPK) were from Cell Signaling Technology (Beverly, MA). Anticaspase-3 antibody was from BD PharMingen (San Diego, CA). Antibodies against actin, ubiquitin, and FAK (polyclonal); secondary antibodies for Western immunoblotting; and protein A/G agarose beads were from Santa Cruz Biotechnology (Santa Cruz, CA). Texas Redconjugated phalloidin, biotin-labeled secondary antibodies, and fluorescein isothiocyanate (FITC) -labeled avidin were from Vector Laboratories (Burlingame, CA). OA and other inhibitors were purchased from Calbiochem (La Jolla, CA). Recombinant human IGF-I was kindly provided by Cephalon, Inc. (Westchester, PA).
Cell Culture
SH-EP human neuroblastoma cells were maintained in DMEM containing 10% calf serum. SH-EP cells transfected with vector (pSFFV) or IGF-IR cDNA [35] were maintained in DMEM containing 10% calf serum and 0.25 mg/ml G418. The cells were serum-starved for 4 hours before each experiment.
Immunoblotting, Immunoprecipitation, and Immunocytochemisty
Immunoblotting and immunoprecipitation were performed as previously described [36] . All experiments were repeated at least three times and typical representative results are presented in the figures. Immunocytochemistry was performed as described previously [37] using an anti-FAK monoclonal antibody and Texas Red phalloidin.
Flow Cytometry
The percentage of apoptotic cells was measured as the percentage of sub-G 0 DNA using flow cytometry as described previously [10] . All results are expressed as the mean percentage of apoptotic cells of at least three experiments ± the standard error of the mean (SEM).
Results
OA Induces Cell Detachment, Actin Stress Fiber Disruption, and Loss of Focal Adhesion Sites in SH-EP Human Neuroblastoma Cells
We recently reported that hyperosmotic media induce apoptosis in neuroblastoma cells [9,38 -40] . One of the earliest events observable with mannitol treatment is disruption of the actin cytoskeleton [11] . The phosphatase inhibitors OA and cytostatin, which inhibit PP1 and PP2A, cause a similar disruption of the actin cytoskeleton [33, 34] and induce apoptosis [41 -43] . Therefore, we were interested in whether comparable biochemical pathways were involved in mannitol-and OA-induced morphological changes and apoptosis. For these studies, we utilized SH-EP human neuroblastoma cells, which we have previously used to characterize mannitol-induced apoptosis [10, 11] . In initial studies, SH-EP cells were serum-starved for 4 hours and then treated for 4 hours with or without 250 nM OA. The control untreated cells were elongated and well spread, and most of the cells were attached to the substrate. However, upon OA treatment, SH-EP cells rounded up and detached from the substrate ( Figure 1A ). Control cells contained well-organized actin stress fibers, as visualized through staining with Texas Red phalloidin ( Figure 1B, left panel) , whereas the actin cytoskeleton was disrupted in OA-treated cells. Immunostaining for the focal adhesion protein FAK revealed a typical punctate pattern at the sites of focal adhesion in control cells. However, this punctate pattern was lost in OA-treated cells, suggesting a loss of focal adhesion formation. These results indicate that initial cellular events occurring after OA treatment are a loss of actin stress fibers and focal adhesions concomitant with rounding up and detachment of cells, similar to our observations in mannitol-treated cells [11] . phosphorylation began to decrease after 2 to 3 hours of OA treatment, and this site was completely dephosphorylated after 4 hours ( Figure 2A ). In contrast, little change occurred in FAK Ser 722 phosphorylation ( Figure 2B ), and the levels of FAK protein remained constant during OA treatment ( Figure 2C ). We next examined the effect of OA on paxillin, a focal adhesion protein that associates with and targets FAK to focal adhesions [45] . OA caused a time-and concentration-dependent loss of paxillin tyrosine phosphorylation ( Figure 2D ). In contrast to FAK, OA also appeared to induce the degradation of paxillin, or at least a reduction in its levels ( Figure 2E ). The decrease in paxillin expression occurred in parallel with reduced electrophoretic mobility, suggesting that OA enhanced the phosphorylation of paxillin on serine or threonine. Finally, OA treatment did not cause a change in the levels of Akt, Erk1/2, or actin ( Figure FAK is completely dephosphorylated. These results strongly suggest that FAK tyrosine phosphorylation is connected to morphological and cytoskeletal changes caused by OA.
OA Induces Concentration-and
Influences of IGF-IR Signaling on OA-Induced FAK Dephosphorylation and Morphological Changes
The activation of IGF-IR is important for transformation and tumor progression in several tumor types [46, 47] . IGF-IR activation and downstream signaling promote both cell proliferation [48 -53] and cell survival [54, 55] and rescue cells from apoptosis caused by a wide variety of agents [56] . In fact, we have shown that IGF-I treatment or IGF-IR overexpression prevents mannitol-induced apoptosis in SH-EP cells [8 -11,39] . Furthermore, IGF-IR activation prevents mannitol-induced FAK dephosphorylation and degradation [11] . IGF-I treatment [42] or IGF-IR overexpression [43] also prevents OA-induced apoptosis in other cell lines. Therefore, we examined the effect of IGF-IR overexpression and activation on OA-induced changes in SH-EP cells.
When serum-starved control SH-EP cells transfected with empty pSFFV vector (SHEP/pSFFV cells) were treated with IGF-I, there was a slight increase in both Tyr 397 ( Figure 4A ) and total FAK tyrosine phosphorylation ( Figure 4C ). In agreement with our previous report [11] , mannitol induced a complete degradation of FAK, as well as a loss of both Tyr 397 and total tyrosine phosphorylation.
Akt is also degraded during mannitol treatment. Given that IGF-I was able to rescue mannitol-induced, but not OA-induced, FAK tyrosine dephosphorylation, we suspected that IGF-I might also prevent the morphological changes caused by mannitol but not OA. Mannitol induced cell detachment and morphological changes associated with apoptosis, including membrane blebbing, loss of contacts with neighboring cells, rounding up, and detachment from the substrate (Figure 5 ), similar to our previous report [11] . As expected, these changes were prevented by IGF-I treatment. Like mannitol, OA induced the rounding up and detachment of cells from the substrate. However, unlike cells exposed to mannitol, cells treated with OA did not display the extensive membrane blebbing typical of apoptosis [11] . Moreover, IGF-I was unable to prevent OA-induced rounding and loss of substrate attachment.
Influences of Integrin Signaling on OA-Induced FAK Dephosphorylation
FAK is activated downstream of both growth factor receptors [17, 18] and integrins [16] . Therefore, because growth factor receptor activation failed to prevent OA-induced 
Reversibility of OA-Induced FAK Dephosphorylation
To determine whether the effects of OA on FAK phosphorylation are reversible, we treated cells with 250 nM OA for 1 to 4 hours, then changed the medium to fresh DMEM. FAK dephosphorylation on Tyr 397 cannot be reversed after 2 hours of OA treatment ( Figure 7) . We also examined the phosphorylation of Akt, which is thought to be dephosphorylated by PP2B [57] . As expected, Akt phosphorylation was enhanced by OA, and switching the medium to fresh DMEM returned Akt phosphorylation to basal levels. IGF-I stimulated Akt phosphorylation in the fresh medium, even after 4 hours of OA treatment, despite the fact that the cells are completely rounded up at this time point. These results show that the effects of OA on FAK are irreversible, suggesting that OA causes a permanent covalent modification of FAK or another upstream signaling molecule. Irreversibility is not a general feature of OA treatment, as its effects on Akt are readily reversible.
Short-Term Effects of OA on Apoptotic Pathways in SH-EP Cells
Our previous studies showed that caspases are actively involved in mannitol-induced or glucose-induced apoptosis [10, 58, 59] . Furthermore, caspase-3 cleavage has been linked to OA-induced apoptosis in other cell types [25, 28, 60] . Therefore, we examined the effect of OA on caspase-3 cleavage in SH-EP cells ( Figure 8A ). We also analyzed the effects of OA on the proteasome/ubiquitin pathway ( Figure 8B ), which participates in apoptosis and 
OA-Induced FAK Dephosphorylation and Degradation
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the breakdown of cellular proteins [61, 62] . After 4 hours of OA treatment, when FAK is fully dephosphorylated and the cells have completed rounding up and detachment, we did not observe caspase-3 cleavage, accumulation of ubiquitinated proteins, or apoptosis ( Figure 8 ). In contrast, a 4-hour treatment with mannitol caused caspase-3 cleavage, protein ubiquitination, and subsequent apoptosis-effects that were blocked by IGF-I (Figure 8 ) [11] .
Long-Term Effects of OA on Apoptotic Pathways in SH-EP Cells
Cells denied anchorage will undergo a form of apoptosis called anoikis [13] . Surprisingly, although OA acid treatment induces cellular detachment, it does not stimulate caspase-3 cleavage, ubiquitination, or accumulation of apoptotic cells. We therefore suspected that the induction of apoptosis was delayed beyond the 4-hour time point. Indeed, when SH-EP cells were treated with 250 nM OA for 8 hours (4 hours after they lost substrate adhesion), they began to show biochemical changes characteristic of apoptosis. First, treatment with OA for 8 hours induced the cleavage of FAK ( Figure 9A ). This cleavage of FAK was complete after 24 hours of OA treatment. We previously reported a similar breakdown of FAK and Akt during mannitol-induced apoptosis in SH-EP cells [11] . In contrast to the degradation of FAK, dephosphorylation of FAK Tyr 397 is easily observed after 4 hours of Figure 9B ). Likewise, protein ubiquitination is not apparent after 4 hours of OA treatment, but is easily detected after 8 hours ( Figure 9C ). These results confirm that apoptotic pathways are triggered only after extended treatment with OA. In agreement with these findings, flow cytometry revealed that OA causes substantial apoptosis only after 8 hours ( Figure 9D ).
Discussion
Anoikis is an apoptotic process that occurs in cells denied cell -matrix or cell -cell attachment [63] . Although many characteristics of apoptosis are recapitulated in anoikis, the caspases, which are critical for executing the apoptotic program, are activated much later in anoikis [64] . Integrin activation of FAK appears particularly crucial for preventing anoikis [65] . However, once anoikis has been initiated, other signaling pathways may protect cells from death, including Akt activation [66] , IGF-I treatment [67] , and insulin receptor overexpression [68] . We have previously shown that exposure of neuroblastoma cells to mannitol causes cell detachment, actin cytoskeleton alterations, FAK dephosphorylation and degradation, and apoptosis, suggesting an anoikis-like death [11] . In the current study, we investigated the events following OA treatment, a known apoptosis inducer, to determine the role of cellular detachment and FAK dephosphorylation in neuroblastoma cell death.
To begin, we examined the effects of OA on the morphology of SH-EP neuroblastoma cells. The initial effect of OA is rounding up of cells and loss of substrate adhesion. These effects are associated with disorganization of the actin cytoskeleton, loss of focal adhesions, tyrosine dephosphorylation of FAK, and degradation of paxillin. At later times, OA induces apoptosis, which is associated with cleavage of FAK, caspase-3, and other signaling proteins, as well as the accumulation of ubiquitinated protein. Thus, tyrosine dephosphorylation and proteolysis of FAK are temporally distinct events associated with different effects of OA.
The morphological effects of OA treatment in SH-EP cells are similar to the effects of OA in other cell types [25, 33, 34, 69] . However, unlike other reports [25, 33, 69] , we did not observe extensive OA-induced membrane blebbing, a characteristic of cells undergoing apoptosis, which is readily detected in mannitol-treated SH-EP cells [11] . Failure to observe OA-induced membrane blebbing is likely due to a delay in the induction of apoptosis until after the 4-hour time point at which we analyzed cell morphology. In fact, caspase-3 cleavage, protein ubiquitination, and the accumulation of apoptotic cells were apparent only after 8 hours of treatment with OA. Our results are supported by studies of OA-induced apoptosis in other cell types. In ERC-18 renal epithelial cells, OA induces cell detachment within 2 hours, caspase cleavage within 6 hours, and membrane blebbing within 6 to 10 hours [25] . This time course is very similar to our results. In this report, they divided the apoptotic process into early, intermediate, and late events, and suggested that different apoptotic and necrotic pathways are involved in each process. Similarly, human lung fibroblasts do not show caspase-3 activation, DNA fragmentation, or the translocation of phosphatidylserine to the outer plasma membrane leaflet until 12 hours after OA treatment [28] . Finally, OA leads to apoptosis in human oral squamous carcinoma cells after 24 hours [26] . These results, along with our findings, suggest that the induction of apoptosis by OA is indirect, occurring subsequent to a loss of focal adhesions and substrate attachment. This is consistent with an anoikis-like death, in which contact-dependent cells undergo apoptosis after loss of substrate attachment [12] . However, it is still possible that other apoptotic signals that we did not test, including p53 activation [31] or expression of Fas ligand and its receptor [26] , are also involved in OA-induced apoptosis in our cells.
The biochemical changes in FAK support our hypothesis that OA-induced apoptosis occurs subsequent to substrate detachment similar to anoikis. OA treatment caused a rapid dephosphorylation of FAK on tyrosine at times (3 -4 hours after OA addition) when focal adhesions and the actin cytoskeleton are disrupted. We also observed the degradation, tyrosine dephosphorylation, and apparent serine/threonine phosphorylation of paxillin at these early time points. Such a connection between cell detachment, cytoskeletal disorganization, and tyrosine dephosphorylation of FAK and paxillin is in agreement with our previous findings and many other reports [22, 70] . Integrin stimulation prevents apoptosis in numerous cell types [63] , potentially through increased attachment of cells to their substrate. In fact, we have previously shown that b1 integrin prevents mannitol-induced apoptosis in SH-EP neuroblastoma cells [71] . However, adhesion of SH-EP cells to fibronectin, the primary extracellular matrix substrate for b1 integrin, did not prevent OAinduced dephosphorylation of FAK Tyr
397
. Therefore, neither IGF-IR expression and activation, nor integrin stimulation is effective at preventing OA-induced apoptosis.
FAK, Akt, and MAP kinase are degraded at later time points (8 -24 h after OA addition) when caspase-3 is cleaved and activated, protein ubiquitination is increased, and apoptosis is readily observed. FAK and Akt cleavage may be carried out directly by activated caspase-3 [22, 72, 73] . Levkau et al. [73] noted that cleavage of FAK appears to precede and contribute to cellular detachment during apoptosis. Similarly, caspase-dependent cleavage of focal adhesion proteins leads to cellular detachment during neuronal apoptosis [74] . However, in other cells, cellular detachment and loss of focal adhesions are not due to caspase cleavage of FAK, but rather, caspase-mediated cleavage of FAK occurs after the loss of focal adhesions [22] . Similarly, we observe FAK degradation only when apoptosis is already occurring (8 -24 h after OA addition), not during the loss of focal adhesion and cell -substrate attachment (3 -4 h after OA addition).
OA [14, 21, 76, 77] . Therefore, the OA-induced tyrosine dephosphorylation of FAK Tyr 397 may cause apoptosis by reducing the activity of phosphatidylinositol-3-kinase. This is exacerbated by the proteolytic degradation of FAK and Akt that occurs after apoptotic pathways are initiated. Like integrin activation, IGF-IR activation leads to downstream activation of the phosphatidylinositol-3-kinase/Akt pathway and provides a signal for cellular survival [40] . Indeed, in our previous [11] and current studies, we showed that IGF-I treatment prevents mannitol-induced apoptosis, FAK cleavage and dephosphorylation, caspase-3 activation, and protein ubiquitination. However, IGF-I was unable to prevent the events induced by OA. This contrasts with the ability of IGF-I to prevent OA-induced apoptosis in mouse embryo fibroblasts [43] , or in rat cerebellar neurons [42] . One possible explanation for this difference may be the concentrations of OA used. Specifically, the studies in mouse embryo fibroblasts and rat cerebellar neurons utilized 5 to 25 nM OA, whereas we used 50 to 500 nM OA. For this reason, we examined the effect of 25 nM OA. Although it takes more than 48 hours for 25 nM OA to cause morphological changes in SH-EP cells, IGF-I is ineffective at preventing the effects of this concentration of OA (data not shown). Therefore, it is more likely that the differences are due to cell-specific sensitivity to OA responses to IGF-I or focal adhesion components. Another possibility is that OA targets the IGF-IR, interfering with its tyrosine kinase activity, as occurs with ethanol treatment in SH-SY5Y neuroblastoma cells [78, 79] .
OA may cause changes in FAK phosphorylation and function by blocking PP1, PP2A, or both phosphatases. FAK associates with PP1 [80] , and the phosphorylation of FAK on serine disrupts its association with other focal adhesion proteins [81, 82] . However, we did not observe an increase in the phosphorylation of FAK on Ser 722 , nor did we observe a reduction in its mobility on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). This suggests that OA does not enhance the phosphorylation of FAK on serine or threonine. A second possibility is that OA stimulates FAK tyrosine dephosphorylation via increased serine phosphorylation of the tyrosine phosphatase SHP2 (also known as PTP1D or Syp) [83, 84] . As mentioned previously, tyrosine dephosphorylation of FAK can disrupt signaling via the phosphatidylinositol-3-kinase/Akt survival pathway. Although this may contribute to FAK dephosphorylation, this does not explain the irreversibility of OA-induced FAK tyrosine dephosphorylation. A more plausible mechanism explanation for the effects of OA involves changes in paxillin. OA inhibits PP2A, which is known to cause the hyperphosphorylation of paxillin on serine [81] . In fact, we found that OA reduces the mobility of paxillin on SDS-PAGE, consistent with its hyperphosphorylation on serine. Serine phosphorylation of paxillin, in turn, can disrupt the formation of FAK/Src/paxillin complexes, thereby preventing FAK activation and signaling [81] . Interestingly, we found that the apparent serine phosphorylation of paxillin also coincides with its degradation. We therefore speculate that OA-induced serine phosphorylation targets paxillin for destruction, in a manner similar to NFnB [85] . The degradation of paxillin, in turn, would prevent FAK from associating with focal adhesions, blocking FAK activation and autophosphorylation. This simple model could explain why the effects of OA on FAK tyrosine phosphorylation are irreversible and insensitive to IGF-IR activation.
In summary, we have shown that OA causes both degradation and dephosphorylation of FAK on Tyr 397 . Dephosphorylation of FAK Tyr 397 coincides with a loss of focal adhesions, disorganization of the actin cytoskeleton, degradation of paxillin, cell rounding, and detachment from the substrate. The degradation of FAK, however, follows the loss of cell -substrate attachment and occurs during active apoptosis and a general breakdown of signaling molecules including Akt and MAP kinase. The effects of OA on FAK Tyr 397 phosphorylation cannot be prevented by IGF-I and are irreversible. Therefore, it appears that OA causes a permanent change in an upstream signaling molecule, perhaps degradation of paxillin, which is responsible for the loss in FAK activation and tyrosine phosphorylation. Finally, these studies suggest that OA causes apoptosis primarily by disrupting cell adhesion.
